Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2266 to 2280 of 8905 results

  1. Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  2. Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  3. Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  4. Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  5. Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  6. Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  7. Extracorporeal shockwave therapy for refractory plantar fasciitis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. Automated percutaneous mechanical lumbar discectomy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Miniature lens system implantation for advanced age-related macular degeneration

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  10. Single-incision short sling mesh insertion for stress urinary incontinence in women

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Electrically-stimulated intravesical chemotherapy for non-muscle invasive bladder cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Parathyroid autofluorescence and parathyroid angiography

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  13. Pancreas SABR

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  14. Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation